Zealand Pharma A/S (ZEAL) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Zealand Pharma A/S

    NASDAQ: ZEAL · Real-Time Price · USD
    17.59
    0.00 (0.00%)
    At close: Sep 29, 2022, 10:00 PM

    Zealand Pharma A/S Cash Flow Statement

    Financials in DKK. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2021
    Period Ending Dec 31, 2021
    Net Income
    		 -1.02B
    Depreciation & Amortization
    		 40.25M
    Stock-Based Compensation
    		 53.5M
    Other Working Capital
    		 -113.55M
    Other Non-Cash Items
    		 -120.06M
    Deferred Income Tax
    		 -1.19M
    Change in Working Capital
    		 -166.32M
    Operating Cash Flow
    		 -1.21B
    Capital Expenditures
    		 -22.13M
    Cash Acquisitions
    		 n/a
    Purchase of Investments
    		 n/a
    Sales Maturities Of Investments
    		 n/a
    Other Investing Acitivies
    		 4.01M
    Investing Cash Flow
    		 -18.12M
    Debt Repayment
    		 n/a
    Common Stock Repurchased
    		 -28.59M
    Dividend Paid
    		 n/a
    Other Financial Acitivies
    		 1.33B
    Financial Cash Flow
    		 1.33B
    Net Cash Flow
    		 168.88M
    Free Cash Flow
    		 -1.23B

    Add to Watchlist